ARTICLES LIST

Clear Search

Select the Article Source National Cancer Institute Office of Dietary Supplements National Institute on Aging Healthfinder.gov National Institute of Child Health and Human Development Centers for Disease Control and Prevention Administration for Children and Families National Institute of Environmental Health Sciences National Library of Medicine National Institute of Allergy and Infectious Diseases National Center for Complementary and Integrative Health National Institute of Neurological Disorders and Stroke NIH Senior Health National Institute of Arthritis and Musculoskeletal and Skin Diseases Health and Human Services National Institute of General Medical Sciences National Institute of Dental and Craniofacial Research National Human Genome Research Institute Food and Drug Administration Center for Tobacco Products Public Health and Medical Emergency Support for a Nation Prepared Office of Disease Prevention and Health Promotion, Healthy People National Institute on Drug Abuse National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases U S Food and Drug Administration National Institute on Deafness and Other Communication Disorders National Heart, Lung, and Blood Institute

Media ID	Source Name	Media Type	Language	Media Name	Media Description	Keywords	Keywords	Link to Article
1398	National Cancer Institute	Html	en	Skin Cancer Prevention (PDQ®)–Patient Version	Expert-reviewed information summary about factors that may influence the risk of developing skin cancer and about research aimed at the prevention of this disease.	skin cancer risk 0.467928 skin cancer 0.941497 cancer treatment 0.38312 cancer prevention trials 0.475588 skin cancer prevention 0.535336 prevention clinical trials 0.429013 protective factors 0.444137 following PDQ summaries 0.42969 PDQ cancer information 0.571591 recurrent nonmelanoma skin 0.412014 squamous cells 0.377891 Clinical Trials section 0.386332 clinical trials 0.585589 cancer information summary 0.499343 melanoma skin cancer 0.517983 breast cancer prevention 0.410906 cancer patients 0.382129 latest published information 0.38194 cancer risk factor 0.448186 NCI’s PDQ 0.391159 UV radiation 0.512203 NCI PDQ cancer 0.462016 basal cell carcinoma 0.591274 new cases 0.414085	PDQ Screening 0.380155 cancer risk factors 0.449906 Cancer prevention 0.618596 cancer protective factor 0.429755 new skin cancers 0.427053 new actinic keratoses 0.38071 Cancer Information Service 0.419558 slightly lower rates 0.381858 nonmelanoma skin cancers 0.666071 Prevention Editorial Board 0.428923 treatment clinical trials 0.387193 National Cancer Institute 0.507676 PDQ documents 0.381747 D. The skin 0.379577 new treatment 0.382048 Cancer Care page 0.40764 PDQ database 0.385226 PDQ summary 0.416284 melanoma prevention trials 0.402284 cancer clinical trials 0.430331 risk factors 0.646155 cancer information summaries 0.426847 nonmelanoma skin cancer 0.802884 comprehensive cancer information 0.42608	CLICK HERE
1518	National Cancer Institute	Html	en	Adult Non-Hodgkin Lymphoma Treatment (PDQ®)–Patient Version	Expert-reviewed information summary about the treatment of adult non-Hodgkin lymphoma.	indolent lymphoma 0.464365 treatment 0.544599 monocytoid B-cell lymphoma 0.420859 plasmablastic lymphoma 0.419927 NK -/T-cell lymphoma 0.426757 small lymphocytic lymphoma 0.423228 gastric malt lymphoma 0.422838 Immunodeficiency-related Burkitt lymphoma 0.415337 aggressive non-Hodgkin lymphoma 0.475259 cutaneous T-cell lymphoma 0.428401 panniculitis-like T-cell lymphoma 0.426066 Non-Hodgkin Lymphoma section 0.42959 extranodal nk-/t-cell lymphoma 0.422171 intestinal T-cell lymphoma 0.425153 cancer cells 0.415937 burkitt lymphoma 0.478875 type 0.432175 Childhood Non-Hodgkin Lymphoma 0.486001 Non-Hodgkin Lymphoma Treatment 0.517724 non-Hodgkin lymphoma depend 0.431176 B-cell non-Hodgkin lymphoma 0.483095 adult non-hodgkin lymphoma 0.682631 Hepatosplenic T-cell lymphoma 0.418177 mantle cell lymphoma 0.469654	clinical trials 0.431842 large cell lymphoma 0.519814 peripheral t-cell lymphoma 0.449001 lymphoblastic lymphoma 0.466951 sporadic Burkitt lymphoma 0.415034 follicular lymphoma 0.466223 lymphoplasmacytic lymphoma 0.484976 anaplastic lymphoma kinase 0.415433 zone lymphoma forms 0.432298 extragastric malt lymphoma 0.451025 non-hodgkin lymphoma 0.940013 bone marrow 0.479363 Mediterranean abdominal lymphoma 0.426917 marginal zone lymphoma 0.520209 aggressive lymphoma 0.473801 lymphoma cells 0.457101 Angioimmunoblastic T-cell lymphoma 0.41858 lymph nodes 0.489794 large B-cell lymphoma 0.570397 radiation therapy 0.436362 anaplastic large cell 0.422021 cancer 0.555203 indolent non-hodgkin lymphoma 0.488068	CLICK HERE
1695	National Cancer Institute	Html	en	High-Dose Vitamin C (PDQ®)–Health Professional Version	Expert-reviewed information summary about the use of high-dose vitamin C as a treatment for people with cancer.	ascorbic acid cause 0.642882 prostate cancer cell 0.630423 /IV ovarian cancer 0.57305 oral ascorbic acid 0.649173 vitamin C therapy 0.612109 vitamin C. 0.610223 cancer information summary 0.591614 weekly ascorbate infusions 0.607343 multiple myeloma patients 0.578578 ovarian cancer 0.574477 cancer patients 0.68661 vitamin 0.72459 high-dose vitamin 0.665873 oral vitamin 0.706163 significant adverse events 0.605455 high-dose IV ascorbate 0.593412 colon cancer cells 0.587994 ascorbic acid treatment 0.848969 metastatic colorectal cancer 0.572155 vitamin C supplements 0.616683 ascorbic acid 0.99701 study 0.585466 current clinical trials 0.571291 case series 0.594589 tumor volume 0.583085	pancreatic cancer patients 0.683645 dehydroascorbic acid 0.640204 terminal cancer patients 0.626123 cancer cells 0.588032 bortezomib growth inhibition 0.576885 high-dose ascorbic acid 0.717915 studies 0.596394 pharmacological ascorbate 0.581055 breast cancer cells. 0.579255 decrease cell proliferation 0.57116 ascorbic acid synthesis 0.660705 cancer cell lines. 0.642672 L-ascorbic acid 0.574809 intracellular ascorbic acid 0.648545 high-dose IV vitamin 0.658734 healthy volunteers 0.583492 inhibitory effect 0.590166 cancer cell death 0.591483 oxidized form 0.602818 cancer cell xenografts 0.58194 ascorbic acid. 0.583971 ascorbate 0.663468 tumor inhibitory effect 0.580256 cancer 0.692622	CLICK HERE
1706	National Cancer Institute	Html	en	Tumor Markers	A fact sheet that defines tumor markers and describes how they can be used to aid diagnosis and treatment.	average risk 0.450619 Urokinase plasminogen activator 0.459684 EGFR gene mutation 0.458827 low recurrence rates 0.462003 potential markers 0.487538 tumor marker 0.811954 Laboratory Improvement Amendments 0.454191 Cancer researchers 0.453927 tumor tissue 0.581622 prostate cancer deaths 0.482408 cancer cells 0.464646 randomized controlled trials 0.451211 cancer therapy 0.462023 Programmed death ligand 0.453669 certain tumor markers 0.637279 Tumor marker levels 0.59758 tumor cells 0.533609 hormone therapy 0.468386 plasminogen activator inhibitor 0.458435 Ovarian Cancer Screening 0.481982 oncotype dx® 0.458204 NCI-sponsored Trial Assigning 0.453214 cancer care 0.460826 European Randomized Study 0.452179	benign prostate conditions 0.461678 BRAF V600 mutations 0.455095 tumor markers 0.944185 ovarian cancer 0.509174 gene mutation 0.459648 Diagnosis research page 0.451878 cancer types 0.497466 BCR-ABL fusion gene 0.458705 follow-up diagnostic tests 0.453464 Beta-human chorionic gonadotropin 0.457581 prostate cancer 0.504684 KRAS gene mutation 0.459458 elevated PSA level 0.472298 ALK gene rearrangements 0.462612 cancer staging 0.458494 accurate tumor markers 0.611174 cancer recurrence 0.463465 different tumor markers 0.654628 HER2-negative breast cancer 0.476048 noncancerous) conditions. 0.470899 cancer 0.625548 Nuclear matrix protein 0.450815 gene expression 0.46063	CLICK HERE
2024	National Cancer Institute	Html	es	Exámenes de detección del cáncer de seno (mama) (PDQ®)–Versión para pacientes	Sumario de información revisada por expertos sobre exámenes que se usan para detectar el cáncer de mama.	siguientes grupos 0.672278 antecedentes familiares 0.758929 riesgo promedio 0.654596 mamas ayuda 0.659647 siguientes aspectos 0.90581 PDQ Exámenes 0.70298 científicos estudian 0.803132 Physician Data Query 0.762154 Estados Unidos 0.676822 Cuánto dolor 0.645226 siguientes características 0.695745 rayos x 0.663809	prevención revisa 0.628149 PDQ Prevención 0.818992 presente síntomas 0.647624 información ayuda 0.645226 National Cancer Institute 0.638447 mamografía dé 0.72651 siguientes riesgos 0.642827 PDQ Aspectos 0.696695 genes brca1 0.6651 siguientes sumarios 0.787128 Instituto Nacional 0.674216	CLICK HERE
2046	National Cancer Institute	Html	es	Exámenes de detección del cáncer de ovario, de trompas de Falopio y primario de peritoneo (PDQ®)–Versión para pacientes	Sumario de información revisada por expertos sobre pruebas que se usan para detectar el cáncer de ovario, de trompas de Falopio y primario de peritoneo.	sumario prevención 0.472534 Visuals Online 0.345966 PDQ Exámenes 0.447043 Physician Data Query 0.632388 Gynecologic Cancers 0.420191 Estados Unidos 0.412228 cuello uterino 0.924963 prevención revisa 0.358425 principal causa 0.399054	uso conjunto 0.372607 información ayuda 0.370212 Características genéticas 0.409802 National Cancer Institute 0.381425 ecografía transvaginal 0.909246 siguientes riesgos 0.361332 siguientes sumarios 0.506181 Instituto Nacional 0.45524	CLICK HERE
2057	National Cancer Institute	Html	es	Cáncer de hueso	Hoja informativa acerca del diagnóstico y tratamiento de los cánceres que se presentan en los huesos.	Lippincott Williams 0.528921 Pediatric Oncology 0.425852 DeVita VT 0.423199 Grandes avances 0.423263 Fischbach FT 0.422317 tejido óseo 0.925192 rayos x 0.477476 American Cancer Society 0.521554 página web guía 0.432205 7th ed 0.466045 altas dosis 0.425962 enfermedades infantiles congénitas 0.446544 Diagnostic Tests 0.424605 fosfatasa alcalina 0.483649 distintos tipos 0.471502 médico pregunta 0.42954 Pizzo P 0.423691 Estados Unidos 0.422015 survival among children 0.439442 Boice JD 0.42308 Rosenberg SA 0.420738 Fraumeni JF 0.42331 tumor óseo 0.736727 Schottenfeld D 0.42165	States SEER Program 0.439663 importante opción 0.422974 mejores formas 0.420225 pequeña cantidad 0.471903 editors.  cancer 0.434055 gammagrafía ósea 0.428461 O'Sullivan B 0.421908 Malawer MM 0.422909 Curtis RE 0.421362 probables beneficios 0.422945 National Cancer Institute 0.447941 4th ed 0.425929 Ries LAG 0.424185 Ewing Sarcoma Family 0.452617 Hellman S 0.421499 Dunning MB 0.422439 Retrieved March 0.423884 emission tomography 0.426368 enzima llamada 0.426279 cabo estudios 0.429851 Helman LJ 0.424392 Gurney JG 0.42319 Poplack DG 0.422887 Miller RW 0.421236	CLICK HERE
4329	National Cancer Institute	Html	en	Cancer Screening	A summary of the benefits and possible harms of cancer screening tests.	time symptoms 0.320649 abnormal tissue 0.346264 False-negative test results 0.440391 screening tests 0.953871 false reassurance 0.328265 potential harms 0.743558 different cancer screening 0.573019 medical care 0.312433	people 0.200595 Early detection 0.319119 additional tests 0.299571 health problems 0.324983 doctors 0.208104 False-positive test results 0.450006 cancer 0.861445	CLICK HERE
15484	National Cancer Institute	Html	null	Cancer Moonshot Milestones	A collection of links to press releases, fact sheets, blog posts, and other materials documenting the latest Moonshot Initiative activities and milestones.			CLICK HERE
16709	National Cancer Institute	Html	es	ALCHEMIST (Estudios sobre la Secuenciación e Identificación de Marcadores para el Mejoramiento de la Terapia Adjuvante para el Cáncer de Pulmón): Preguntas y respuestas	ALCHEMIST comprende tres estudios clínicos integrados de medicina de precisión diseñados para identificar a personas con cáncer de pulmón en estadio inicial cuyos tumores tienen ciertos cambios genéticos poco comunes. También buscan evaluar si los tratamientos con medicamentos que combaten esos cambios moleculares pueden mejorar la supervivencia	Geoffrey Oxnard 0.313105 estudios clínicos alchemist 0.419541 genes egfr 0.537115 tumor carcinoide 0.318935 gen alk 0.998441 estudio alchemist 0.428836 cáncer nsclc 0.336759 Clinical Trials 0.385899 Washington University 0.311286 estudios alchemist hombres 0.406835 Dana-Farber Cancer Institute 0.323728 estadio ib 0.321816 largo plazo 0.311737 Cáncer ECOG-ACRIN 0.357818 Clinical Laboratory Improvement 0.323435 Cancer Enrichment Marker 0.325429 Cancer Genome Analysis 0.324094 Pasi A 0.313281 compañías farmacéuticas socias 0.322405 National Human Genome 0.322496 Instituto Nacional 0.327493	estadio iiia 0.321214 David E 0.311651 Terapia Adjuvante 0.312862 NCI Community Oncology 0.329248 Genoma Humano 0.311302 Ramaswamy Govindan 0.314989 gen egfr 0.724341 alchemist correspondientes 0.435182 Estados Unidos 0.373254 Texas Southwestern Medical 0.321883 cabo estudios 0.336005 principales objetivos 0.311051 Vysis ALK break-apart 0.345879 compañía response genetics 0.320675 estudios alchemist 0.840169 Astellas Pharma US 0.321115 Cancer Genomics 0.314435 Oncología NRG 0.312826 radioterapia posoperatorias 0.315764 Sequencing Trials 0.317534 Institutos Nacionales 0.331134	CLICK HERE